Buprenorphine and Naloxone Combination Study - 10

Completed · Phase 1

Conditions studied: Heroin Dependence, Opioid-Related Disorders

In brief

The purpose of this study is to examine pharmacokinetics and dose proportionality of sublingual tablets containing varying doses of buprenorphine and naloxone.

Key facts

Study ID

NCT00015288

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

1996-11-01

Last updated by the study team

2017-01-12

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male/Female between the ages of 21 and 45. Within 15% of ideal body weight. No oral pathology that would interfere with the sublingual absorption of the medication. Experienced in the use of opiates but not dependent.

You may not qualify if…

• LFT's exceeding than 3x's normal. History of seizure. Opiate dependent.

Where it is running

• New York MDRU — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.